美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

信息服務

4.20

-0.0700-1.64%

成交量：26.41萬

成交額：111.46萬

市值：2.01億

市盈率：22.07

高：4.30

開：4.27

低：4.13

收：4.27

52周最高：6.45

52周最低：3.17

股本：4,788.41萬

流通股本：3,423.30萬

量比：0.86

換手率：0.77%

股息：0.18

股息率：4.29%

每股收益(TTM):0.1903

每股收益(LYR):0.1900

淨資產收益率：9.78%

總資產收益率：5.35%

市淨率：2.12

市盈率(LYR):22.11

資料載入中...

總覽公司新聞資訊公告

港股異動 | 和譽-B(02256)再升逾9% 貝捷邁全球III期MANEUVER研究結果榮登《柳葉刀》

智通财经网

和譽-B(02256)：《柳葉刀》(The Lancet)發布貝捷邁®全球III期MANEUVER研究結果

信息服務集團發布2026年第一季度業績指引：營收預計6050萬至6150萬美元，調整後EBITDA達750萬至850萬美元

阿斯利康重磅炸彈在國內啓動新 III 期臨床

FDA要求開展III期試驗 uniQure(QURE.US)亨廷頓病基因療法上市受阻股價重挫約33%

沃森生物：公司四價流腦結合疫苗目前處於III期臨床研究階段

瑞博生物-B(06938)：RBD7022注射液即將於中國啓動用於治療高血脂症適應症的 III期臨床試驗

iza-bren公告III期結果；君實生物等藥企發布業績快報 | 健訊Daily

21世纪经济报道

港股異動 | 基石藥業-B(02616)尾盤升逾8% 舒格利單抗III期非小細胞肺癌新適應症獲英國MHRA批准

聯儲局鮑曼：巴塞爾III終版提案將於下月出爐——市場快訊

諾誠健華新型BCL2抑制劑Mesutoclax聯合奧布替尼一線治療CLL/SLL的註冊性III期臨床試驗完成患者入組

瞄準數字資產與AI賽道，Dune Acquisition III遞交1.5億美元SPAC IPO申請

港股異動 | 基石藥業-B(02616)再升逾6% 月內升逾25% 舒格利單抗III期NSCLC獲英國正式批准

港股異動 | 基石藥業-B(02616)升逾5% 舒格利單抗III期非小細胞肺癌新適應症獲英國MHRA批准

百利天恒(688506.SH)：iza-bren(EGFR×HER3雙抗ADC)用於局部晚期或轉移性三陰乳腺癌III期臨試期中分析達到主要終點

基石藥業-B(02616)：舒格利單抗III期小細胞肺癌新適應症獲英國MHRA批准

智通财经网

倍擇瑞®治療未控制哮喘的KALOS與LOGOS III期試驗取得具有臨床意義的陽性結果相關成果發表於《柳葉刀-呼吸病學雜誌》

對外投資合作信息服務

商务部网站

沃森生物：公司九價HPV疫苗目前處於III期臨床研究階段

中國生物製藥(01177)升5% TQB2102 III期臨床完成入組此前Ib期ASCO數據良好

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/III/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服務","latestPrice":4.2,"timestamp":1773172248764,"preClose":4.27,"halted":0,"volume":264077,"delay":0,"changeRate":-0.01639344262295068,"floatShares":34233044,"shares":47884104,"eps":0.190275,"marketStatus":"交易中","change":-0.07,"latestTime":"03-10 15:51:51 EDT","open":4.27,"high":4.301,"low":4.129,"amount":1114630.7258350002,"amplitude":0.040281,"askPrice":4.21,"askSize":880,"bidPrice":4.19,"bidSize":1108,"shortable":3,"etf":0,"ttmEps":0.190275,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":4.27,"dividendRate":0.042857,"preHourTrading":{"tag":"盘前","latestPrice":4.2526,"preClose":4.27,"latestTime":"08:42 EDT","volume":1995,"amount":8483.937,"timestamp":1773146523311,"change":-0.0174,"changeRate":-0.004075,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.27,"latestTime":"19:54 EDT","volume":9114,"amount":38911.7606,"timestamp":1773100471712,"change":-0.03,"changeRate":-0.007026,"amplitude":0.007026},"volumeRatio":0.857107,"impliedVol":1.5147,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34233044,"roa":"5.35%","roe":"9.78%","lyrEps":0.19,"volumeRatio":0.857107,"shares":47884104,"dividePrice":0.18,"high":4.301,"amplitude":0.040281,"preClose":4.27,"low":4.129,"week52Low":3.1729,"pbRate":"2.12","psRate":"0.82","week52High":6.4495,"institutionHeld":0.6668,"latestPrice":4.2,"committee":0.114688,"eps":0.190275,"divideRate":0.042857,"volume":264077,"delay":0,"ttmEps":0.190275,"open":4.27,"prevYearClose":5.78,"prevWeekClose":4.53,"prevMonthClose":4.81,"prevQuarterClose":5.78,"fiveDayClose":4.77,"twentyDayClose":5.22,"sixtyDayClose":6.1,"dividendPayoutRate":0.9280598907982862,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.03333720106347336},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2026-03-20","symbol":"III","amount":0.045,"announcedDate":"2026-03-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-26"},{"market":"US","date":"2026-03-05","symbol":"III","fiscalQuarterEnding":"2025/12","expectedEps":0.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":0.06},{"date":"2025-12-05","symbol":"III","amount":0.045,"announcedDate":"2025-11-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-05","defaultRemindTime":1764945000000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-05","currency":"USD","dateTimestamp":1764910800000,"payDate":"2025-12-19"},{"market":"US","date":"2025-11-03","symbol":"III","fiscalQuarterEnding":"2025/09","expectedEps":0.06,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"pre","actualEps":0.07},{"date":"2025-10-08","symbol":"III","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1759953600000,"name":null,"time":"盤後","dateTimestamp":1759896000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679544000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2026-03-09","current":21.936145,"percent":0.562602,"low":-221.876594,"twenty":12.58915,"median":18.866214,"eighty":31.923706,"high":85.733259,"avg":3.882074,"sd":60.790407,"marketCap":216914991},"quantilePoints":[{"date":"2021-03-12","current":77.651845,"twenty":24.664612,"median":33.630766,"eighty":52.202094,"marketCap":213930833},{"date":"2021-03-19","current":71.502943,"twenty":26.272494,"median":33.737549,"eighty":52.523833,"marketCap":196990608},{"date":"2021-03-26","current":76.77343,"twenty":26.854371,"median":33.859576,"eighty":52.626372,"marketCap":211510801},{"date":"2021-04-01","current":78.003211,"twenty":26.956092,"median":33.90293,"eighty":52.747595,"marketCap":214898846},{"date":"2021-04-09","current":75.895016,"twenty":27.210395,"median":33.991802,"eighty":52.906055,"marketCap":209090769},{"date":"2021-04-16","current":76.422065,"twenty":27.379781,"median":34.193624,"eighty":53.109266,"marketCap":210542788},{"date":"2021-04-23","current":77.124796,"twenty":27.464698,"median":34.23369,"eighty":53.271145,"marketCap":212478813},{"date":"2021-04-30","current":79.935723,"twenty":27.596809,"median":34.39907,"eighty":53.663807,"marketCap":220222916},{"date":"2021-05-07","current":85.733259,"twenty":27.758845,"median":34.72983,"eighty":53.929654,"marketCap":236195128},{"date":"2021-05-14","current":34.582604,"twenty":27.90985,"median":34.72983,"eighty":53.929654,"marketCap":260718251},{"date":"2021-05-21","current":37.193814,"twenty":27.984267,"median":34.89521,"eighty":53.929654,"marketCap":280404160},{"date":"2021-05-28","current":37.32119,"twenty":28.127158,"median":35.060591,"eighty":53.929654,"marketCap":281364448},{"date":"2021-06-04","current":35.665301,"twenty":28.201568,"median":35.178625,"eighty":53.929654,"marketCap":268880701},{"date":"2021-06-11","current":36.811685,"twenty":28.275979,"median":35.34686,"eighty":53.929654,"marketCap":277523295},{"date":"2021-06-18","current":35.283172,"twenty":28.317177,"median":35.460054,"eighty":53.929654,"marketCap":265999836},{"date":"2021-06-25","current":35.983741,"twenty":28.42477,"median":35.600769,"eighty":53.929654,"marketCap":271281422},{"date":"2021-07-02","current":38.27651,"twenty":28.559204,"median":35.741483,"eighty":53.929654,"marketCap":288566610},{"date":"2021-07-09","current":38.212822,"twenty":28.661781,"median":35.920053,"eighty":53.929654,"marketCap":288086466},{"date":"2021-07-16","current":36.174805,"twenty":28.841499,"median":36.238493,"eighty":53.929654,"marketCap":272721854},{"date":"2021-07-23","current":38.085446,"twenty":29.02216,"median":36.365869,"eighty":53.929654,"marketCap":287126177},{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-16","current":29.987043,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":231380025},{"date":"2025-05-23","current":29.29984,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":226077566},{"date":"2025-05-30","current":29.237367,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":225595524},{"date":"2025-06-06","current":29.424786,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":227041650},{"date":"2025-06-13","current":29.862097,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":230415942},{"date":"2025-06-20","current":29.612205,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":228487775},{"date":"2025-06-27","current":28.862529,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":222703274},{"date":"2025-07-03","current":31.923706,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":246323318},{"date":"2025-07-11","current":31.486395,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":242949026},{"date":"2025-07-18","current":29.237367,"twenty":12.58915,"median":18.866214,"eighty":34.89521,"marketCap":225595524},{"date":"2025-07-25","current":28.425218,"twenty":12.58915,"median":18.866214,"eighty":34.834126,"marketCap":219328982},{"date":"2025-08-01","current":26.925866,"twenty":12.58915,"median":18.866214,"eighty":34.784891,"marketCap":207759981},{"date":"2025-08-08","current":25.754678,"twenty":12.58915,"median":18.866214,"eighty":34.77297,"marketCap":202457522},{"date":"2025-08-15","current":30.470866,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":239531480},{"date":"2025-08-22","current":29.489913,"twenty":12.58915,"median":18.866214,"eighty":34.221243,"marketCap":231820205},{"date":"2025-08-29","current":31.39051,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":246760801},{"date":"2025-09-05","current":32.432773,"twenty":12.58915,"median":18.85295,"eighty":34.118522,"marketCap":254954031},{"date":"2025-09-12","current":32.126225,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":252544257},{"date":"2025-09-19","current":33.965513,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":267002898},{"date":"2025-09-26","current":35.314324,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":277605901},{"date":"2025-10-03","current":34.639918,"twenty":12.58915,"median":18.866214,"eighty":34.639918,"marketCap":272304399},{"date":"2025-10-10","current":33.842894,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":266038988},{"date":"2025-10-17","current":33.413727,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":262665306},{"date":"2025-10-24","current":34.088132,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":267966807},{"date":"2025-10-31","current":33.536346,"twenty":12.58915,"median":18.866214,"eighty":34.748399,"marketCap":263629215},{"date":"2025-11-07","current":28.380485,"twenty":12.58915,"median":18.866214,"eighty":34.701228,"marketCap":277248962},{"date":"2025-11-14","current":25.733601,"twenty":12.58915,"median":18.866214,"eighty":34.517299,"marketCap":251391546},{"date":"2025-11-21","current":24.557208,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":239899361},{"date":"2025-11-28","current":26.370814,"twenty":12.58915,"median":18.866214,"eighty":34.210751,"marketCap":257616479},{"date":"2025-12-05","current":28.282453,"twenty":12.58915,"median":18.866214,"eighty":33.965513,"marketCap":276291280},{"date":"2025-12-12","current":29.409829,"twenty":12.58915,"median":18.866214,"eighty":33.842894,"marketCap":287304624},{"date":"2025-12-19","current":29.26278,"twenty":12.58915,"median":18.866214,"eighty":33.529773,"marketCap":285868100},{"date":"2025-12-26","current":29.066715,"twenty":12.58915,"median":18.866214,"eighty":33.430508,"marketCap":283952736},{"date":"2026-01-02","current":28.331469,"twenty":12.58915,"median":18.866214,"eighty":33.342648,"marketCap":276770121},{"date":"2026-01-09","current":29.164747,"twenty":12.58915,"median":18.866214,"eighty":33.210859,"marketCap":284910418},{"date":"2026-01-16","current":29.80196,"twenty":12.58915,"median":18.866214,"eighty":33.054432,"marketCap":291135352},{"date":"2026-01-23","current":27.792289,"twenty":12.58915,"median":18.866214,"eighty":32.903351,"marketCap":271502869},{"date":"2026-01-30","current":27.400158,"twenty":12.58915,"median":18.866214,"eighty":32.739321,"marketCap":267672141},{"date":"2026-02-06","current":24.998355,"twenty":12.58915,"median":18.866214,"eighty":32.548436,"marketCap":244208930},{"date":"2026-02-13","current":22.35147,"twenty":12.58915,"median":18.866214,"eighty":32.359621,"marketCap":218351514},{"date":"2026-02-20","current":22.841634,"twenty":12.58915,"median":18.866214,"eighty":32.126225,"marketCap":223139924},{"date":"2026-02-27","current":23.429831,"twenty":12.58915,"median":18.866214,"eighty":32.068687,"marketCap":228886017},{"date":"2026-03-06","current":24.400849,"twenty":12.58915,"median":18.866214,"eighty":31.936898,"marketCap":227928335},{"date":"2026-03-09","current":23.221817,"twenty":12.58915,"median":18.866214,"eighty":31.923706,"marketCap":216914991}],"updateTime":1773170237551},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618985985","title":"港股異動 | 和譽-B(02256)再升逾9% 貝捷邁全球III期MANEUVER研究結果榮登《柳葉刀》","url":"https://stock-news.laohu8.com/highlight/detail?id=2618985985","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618985985?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 13:36","pubTimestamp":1773121010,"startTime":"0","endTime":"0","summary":"和誉-B(02256)再涨超9%，截至发稿，涨8.76%，报12.91港元，成交额2199.69万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260310/20260310133720_71529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260310/20260310133720_71529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00B5MMRT66.SGD","BK4588","02256","III","LU2476274308.USD","LU2488822045.USD","LU2476274720.SGD","BK4585","LU2778985437.USD","VXUS","BK1161","IE00B543WZ88.USD","BK4134","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2618692617","title":"和譽-B(02256)：《柳葉刀》(The Lancet)發布貝捷邁®全球III期MANEUVER研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2618692617","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618692617?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 08:03","pubTimestamp":1773014618,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布，其自主研发的新型、口服、高选择性且高效的小分子CSF-1R抑制剂贝捷迈®(盐酸匹米替尼胶囊，ABSK021)的全球多中心III期MANEUVER研究结果，于3月5日(西欧时间)正式发表于国际医学期刊《柳叶刀》 (The Lancet)1。此次发表标志着和誉医药这一创新疗法在临床研究质量、数据完整性及国际学术认可度方面取得了重要里程碑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","LU2476274308.USD","BK1161","LU2476274720.SGD","LU2778985437.USD","02256","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2488822045.USD","III","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"1125385117","title":"信息服務集團發布2026年第一季度業績指引：營收預計6050萬至6150萬美元，調整後EBITDA達750萬至850萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125385117","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125385117?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 05:30","pubTimestamp":1772746217,"startTime":"0","endTime":"0","summary":"信息服务集团（Information Services Group）近日公布了2026年第一季度的财务预期。根据公司指引，当期营收预计将落在6050万至6150万美元区间，调整后的税息折旧及摊销前利润（EBITDA）预计为750万至850万美元。\n这一业绩指引反映出公司对核心业务持续增长的信心。通过优化运营效率和深化客户合作，信息服务集团正稳步推进其战略目标。市场将密切关注该公司后续的财务表现，以评估其长期发展潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","III"],"gpt_icon":0},{"id":"2617577516","title":"阿斯利康重磅炸彈在國內啓動新 III 期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2617577516","media":"求实药社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617577516?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 12:03","pubTimestamp":1772683402,"startTime":"0","endTime":"0","summary":"来源：丁香园Insight数据库3 月 4 日，药物临床试验登记与信息公示平台官网显示，阿斯利康登记了一项特泽利尤单抗用于鼻内镜下鼻息肉评分 ≥4 分慢性鼻窦炎伴鼻息肉成人患者附加维持治疗的 IIIb 期临床研究。用药方案为每 4 周皮下注射一次，合计 24 周。通过精准阻断 TSLP，特泽利尤单抗可从源头抑制相关炎症通路激活，从而缓解疾病症状。目前，特泽利尤单抗已经在美国、日本、欧盟获批 2 项适应症，分别是哮喘、慢性鼻窦炎伴鼻息肉病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030514022597a82446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030514022597a82446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU1829250122.USD","LU0289739699.SGD","BK4588","LU0889565916.HKD","LU2456880835.USD","BK4568","LU2462157665.USD","LU0058720904.USD","III","AZN","BK4585","LU2417539215.USD","IE00B3T34201.USD","BK4007","LU2236285917.USD","LU0320765992.SGD","BK4134"],"gpt_icon":0},{"id":"2616966003","title":"FDA要求開展III期試驗 uniQure(QURE.US)亨廷頓病基因療法上市受阻股價重挫約33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616966003","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616966003?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 09:50","pubTimestamp":1772502622,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基因治疗公司uniQure原本寄望其亨廷顿病候选药物AMT-130能获得美国FDA的加速批准，但这一期望近日落空。FDA明确告知这家生物制药公司，需开展一项随机、双盲、假手术对照的III期临床试验。受此消息影响，公司股价周一收盘大跌约33%。根据公司发布的新闻稿，uniQure此前计划基于一项与外部对照比较的I/II期研究数据申请批准。uniQure表示，将在第二季度请求与FDA召开B类会议，商讨后续推进路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK4139","LU0109394709.USD","BK4134","LU0889565916.HKD","QURE","LU0320765992.SGD"],"gpt_icon":0},{"id":"2616693389","title":"沃森生物：公司四價流腦結合疫苗目前處於III期臨床研究階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2616693389","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616693389?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:00","pubTimestamp":1772438425,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物03月02日在投资者关系平台上答复投资者关心的问题。康希诺 ACYW135 群脑膜炎球菌多糖结合疫苗临床启动晚于公司，却已于2021 年 12 月获批上市。而公司同款疫苗进入三期临床多年，至今仅披露 “撰写报告”，无明确上市时间表。公司四价流脑结合疫苗目前处于III期临床研究阶段，公司在研疫苗的研发若有实质性和阶段性进展公司会及时披露，后续进展情况请关注公司披露的相关信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260302/32037575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159646","III","BK0046","BK0239","BK4134","BK0077","BK0070","300142"],"gpt_icon":0},{"id":"2616877702","title":"瑞博生物-B(06938)：RBD7022注射液即將於中國啓動用於治療高血脂症適應症的 III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2616877702","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616877702?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 08:11","pubTimestamp":1772410260,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞博生物-B(06938)公布，集团自主研发的RBD7022注射液已由合作方齐鲁制药有限公司(齐鲁制药)完成III期临床试验登记公示，即将启动III期临床试验。RBD7022注射液是一款靶向PCSK9的siRNA药物。PCSK9是一种酶，在调节体内胆固醇，尤其是通常被称为“LDL-C”或“坏胆固醇”的低密度脂蛋白(LDL)胆固醇的水平方面起关键作用，可作为管理高胆固醇血症的一种治疗选择，旨在降低与高胆固醇水平相关的心血管疾病风险。2023年12月，公司将RBD7022注射液在中国内地、中国香港和中国澳门开发、生产和商业化的独家权利授予齐鲁制药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06938","BK4134","BK1161","III"],"gpt_icon":0},{"id":"2614289542","title":"iza-bren公告III期結果；君實生物等藥企發布業績快報 | 健訊Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2614289542","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614289542?lang=zh_tw&edition=fundamental","pubTime":"2026-02-28 08:06","pubTimestamp":1772237206,"startTime":"0","endTime":"0","summary":"国家药监局：2025年共收到创新医疗器械特别审批申请457项近日，国家药监局发布2025年度创新医疗器械等产品注册审批情况。2025年，国家药监局按照《创新医疗器械特别审查程序》《医疗器械优先审批程序》继续做好相关产品的审查工作，共收到创新医疗器械特别审批申请457项，其中104项获准进入创新医疗器械特别审查程序；收到优先申请38项，其中26项获准优先审批。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602283657320729.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602283657320729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688180","BK4134","BK1583","BK1515","BK1161","III","BK0239","01877"],"gpt_icon":0},{"id":"2614882728","title":"港股異動 | 基石藥業-B(02616)尾盤升逾8% 舒格利單抗III期非小細胞肺癌新適應症獲英國MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614882728","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614882728?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 15:54","pubTimestamp":1772178879,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B尾盘涨超8%，截至发稿，涨6.73%，报6.66港元，成交额9312.3万港元。消息面上，基石药业此前宣布，舒格利单抗的新适应症申请已获英国MHRA批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因子受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期NSCLC成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1161","VT","02616","BK1574","BK4585","BK4134","III","VXUS"],"gpt_icon":0},{"id":"1128180907","title":"聯儲局鮑曼：巴塞爾III終版提案將於下月出爐——市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1128180907","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128180907?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 02:44","pubTimestamp":1772131472,"startTime":"0","endTime":"0","summary":"美联储负责监管事务的副主席米歇尔·鲍曼在听证会上向参议员们表示，旨在使美国银行监管与国际巴塞尔III标准接轨的提案将在三月底前公布。鲍曼指出，三大联邦银行监管机构——美联储、联邦存款保险公司（FDIC）和货币监理署（OCC）——已就该提案达成共识。\n南达科他州共和党参议员迈克·朗兹指出，该项目酝酿已久。此前由前副主席迈克尔·巴尔推动的巴塞尔III改革尝试未能成功。鲍曼谈及自己及其同由特朗普任命的FDIC和OCC负责人时表示：\"我认为我们正在以创纪录的速度推进工作。\"\n（完）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLT","BK4134","BK4585","US12M.BOND","III","US3Y.BOND","US7Y.BOND","US10Y.BOND","BK4588","TMF","BIL","US2Y.BOND","US5Y.BOND","TLTW","US30Y.BOND","US6M.BOND"],"gpt_icon":0},{"id":"2614062136","title":"諾誠健華新型BCL2抑制劑Mesutoclax聯合奧布替尼一線治療CLL/SLL的註冊性III期臨床試驗完成患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2614062136","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614062136?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 10:40","pubTimestamp":1772073636,"startTime":"0","endTime":"0","summary":"人民财讯2月26日电，诺诚健华2月26日宣布，公司自主研发的新型BCL2抑制剂mesutoclax（ICP-248）联合BTK抑制剂奥布替尼一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（CLL/SLL）的注册性III期临床试验已经完成患者入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602263655089844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969","BK1574","BK1161","III","688428","BK4134","BK0239"],"gpt_icon":0},{"id":"2614670859","title":"瞄準數字資產與AI賽道，Dune Acquisition III遞交1.5億美元SPAC IPO申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2614670859","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614670859?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 14:52","pubTimestamp":1772002329,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于数字资产、体育娱乐、软件即服务及人工智能领域的特殊目的收购公司Dune Acquisition III，于周二向美国证券交易委员会递交文件，计划通过首次公开募股筹资至多1.5亿美元。Dune Acquisition III由首席执行官兼董事长Carter Glatt领导，他曾任GTY公司企业发展主管兼高级副总裁。管理层的过往SPAC项目包括：于2023年上市并完成与氢气供应商Global Gas业务合并的Dune Acquisition，以及于2025年上市的Dune Acquisition II。Dune Acquisition III已于2025年11月6日以保密方式递交申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","DUNEU"],"gpt_icon":0},{"id":"2614777939","title":"港股異動 | 基石藥業-B(02616)再升逾6% 月內升逾25% 舒格利單抗III期NSCLC獲英國正式批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614777939","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614777939?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 14:04","pubTimestamp":1771999477,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B再涨超6%，月内累计涨幅已超25%。消息面上，2月23日，基石药业宣布，其PD-L1抗体舒格利单抗针对III期非小细胞肺癌的新适应症，已正式取得英国药品和医疗保健用品管理局的批准。此外，基石药业核心资产CS2009用于晚期实体瘤的II期临床试验IND申请近期获得FDA批准。CS2009用于晚期实体瘤的II期新药临床试验申请获美国食品药品监督管理局批准，标志着这一创新免疫疗法的全球开发取得重要进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","VT","BK4588","BK4134","02616","BK1574","III","VXUS","BK1161"],"gpt_icon":0},{"id":"2613750586","title":"港股異動 | 基石藥業-B(02616)升逾5% 舒格利單抗III期非小細胞肺癌新適應症獲英國MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2613750586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613750586?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 10:30","pubTimestamp":1771900210,"startTime":"0","endTime":"0","summary":"消息面上，基石药业昨日公布，舒格利单抗的新适应症申请已获英国药品和医疗保健用品管理局批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因数受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期小细胞肺癌成人患者。继欧盟委员会批准后，舒格利单抗III期NSCLC新适应症再获英国MHRA批准，这是该产品在英国获得的第二个适应症批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","02616","VT","BK4585","BK1161","III","BK1574","BK4588","BK4134"],"gpt_icon":0},{"id":"2613820071","title":"百利天恒(688506.SH)：iza-bren(EGFR×HER3雙抗ADC)用於局部晚期或轉移性三陰乳腺癌III期臨試期中分析達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2613820071","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613820071?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 16:56","pubTimestamp":1771836964,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒 披露公告，关于iza-bren用于局部晚期或转移性三阴乳腺癌III期临床试验的期中分析达到主要终点的事项，该III期临床研究独立数据监查委员会，在预设的期中分析中，建议：“基于现有的分析结果，与监管沟通提前申报，同时继续对受试者进行随访”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","ADC","BK0239","BK4080","BK4231","91194","688506","BK4134","02615"],"gpt_icon":0},{"id":"2613027209","title":"基石藥業-B(02616)：舒格利單抗III期小細胞肺癌新適應症獲英國MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2613027209","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613027209?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 08:17","pubTimestamp":1771805849,"startTime":"0","endTime":"0","summary":"基石药业-B(02616)发布公告，舒格利单抗的新适应症申请已获英国药品和医疗保健用品管理局(MHRA)批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因数受体(EGFR)敏感突变或ALK、ROS1基因组变异、在含铂放化疗(CRT)后未出现疾病进展的、不可切除的III期小细胞肺癌(NSCLC)成人患者。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02616","BK4134","BK1161","III","BK1574"],"gpt_icon":0},{"id":"2611713190","title":"倍擇瑞®治療未控制哮喘的KALOS與LOGOS III期試驗取得具有臨床意義的陽性結果 相關成果發表於《柳葉刀-呼吸病學雜誌》","url":"https://stock-news.laohu8.com/highlight/detail?id=2611713190","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611713190?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 15:43","pubTimestamp":1770968580,"startTime":"0","endTime":"0","summary":"完整结果可查阅《柳叶刀-呼吸病学杂志》。KALOS与LOGOS试验表明，布地格福固定三联吸入疗法能够同时发挥ICS、LAMA和LABA的疗效，改善肺功能。KALOS与LOGOS研究结果有力地证实，布地格福固定三联吸入疗法有望为该类型哮喘患者带来健康获益。\" 在KALOS与LOGOS试验中，布地格福吸入气雾剂未出现新的安全性或耐受性问题。KALOS与LOGOS研究共纳入约4300名随机分组患者。KALOS和LOGOS试验的主要终点和治疗比较方案因监管申报途径的不同而有所差异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4887756_ZH87756_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2456880835.USD","BK4134","LU0058720904.USD","BK4588","LU2417539215.USD","III","LU2236285917.USD","LU1829250122.USD","LU0109394709.USD","BK4568","LU0289739699.SGD","LU0320765992.SGD","LU0889565916.HKD","LU2462157665.USD","AZN","BK4007","BK4585"],"gpt_icon":0},{"id":"2611915245","title":"對外投資合作信息服務","url":"https://stock-news.laohu8.com/highlight/detail?id=2611915245","media":"商务部网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611915245?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 14:11","pubTimestamp":1770963060,"startTime":"0","endTime":"0","summary":"关于公布对外劳务合作企业名单的说明根据《对外劳务合作管理条例》第五条，从事对外劳务合作，应当按照盛自治区、直辖市人民政府的规定，经省级或者设区的市级人民政府商务主管部门批准，取 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260213/c674792752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["III","BK4134"],"gpt_icon":0},{"id":"2610161154","title":"沃森生物：公司九價HPV疫苗目前處於III期臨床研究階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2610161154","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610161154?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 15:25","pubTimestamp":1770708314,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物(300142)02月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司九价HPV疫苗目前III期临床、数据统计、申报准备的最新节点是否顺利？预计提交上市申请的时间窗口与后续规划如何？相比同类产品的临床优势、产能规划、市场定位有哪些积极亮点？沃森生物回复：尊敬的投资者，您好！公司九价HPV疫苗目前处于III期临床研究阶段，公司在研疫苗的研发若有实质性和阶段性进展公司会及时披露，后续进展情况请关注公司披露的相关信息。谢谢！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260210/32009687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0077","BK0070","BK0239","III","300142","BK4134","BK0046","159646"],"gpt_icon":0},{"id":"2610699154","title":"中國生物製藥(01177)升5% TQB2102 III期臨床完成入組 此前Ib期ASCO數據良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2610699154","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610699154?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 10:52","pubTimestamp":1770691959,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国生物制药(01177)短线拉高，截止发稿， 升5.15%，报6.94港元，成交额1.94亿港元。公司公告公布，集团自主研发的国家1类创新药TQB2102“HER2双抗ADC”正在开展一项“评价注射用TQB2102对比研究者选择的化疗在HER2低表达复发╱转移性乳腺癌中有效性和安全性的随机、开放、平行对照的III期临床试验(TQB2102-III-01)”，近期已完成全部受试者入组。在2025年美国临床肿瘤学会(ASCO)年会上，集团公布了TQB2102用于HER2低表达晚期乳腺癌的 Ib期临床研究结果，显示出良好的疗效与安全性。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974849","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","HK0000165453.HKD","IE00BZ08YT58.USD","III","BK1515","BK4134","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","01177","BK1191","BK1521"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":153,"code":"91000000","status":"200"}]}}